ASTRAZENECA - United Kingdom 

Ranking results:

Past rankings:

2020
Criterium:Position:
Overall Score:600-700
Total Project Funding per Partner:> 1000
Total Number of Projects:500-600
2019
Criterium:Position:
Overall Score:200-300
Total Project Funding per Partner:600-700
Total Number of Projects:100-200

Ranking timeline:

Project Participation Performance(2019-01-01 - 2022-12-31 ):

Total Project Funding:

Funding per Partner:

Projects:

Leadership:

Total number of projects: 39
As coordinator: 0
As participant: 39
Sole participant: 0
Coordinator / Participant Ratio: 0*

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2022 0 23.969.456 1.157.419 5
2021 0 47.126.142 2.102.060 10
2020 0 49.365.492 1.086.449 8
2019 0 170.536.767 3.310.038 16

Networking:

Partners:

Institution:Projects [No]:
BAYER13
PFIZER LIMITED13
NOVARTIS PHARMA12
JANSSEN PHARMACEUTICA NV11
SANOFIAVENTIS11
F HOFFMANNLA ROCHE9
KATHOLIEKE UNIVERSITEIT LEUVEN8
KAROLINSKA INSTITUTE7
UNIVERSITAIR MEDISCH CENTRUM UTRECHT7
ABBVIE INC6
TAKEDA PHARMACEUTICALS INTERNATIONAL6
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD6
BOEHRINGER INGELHEIM PHARMA GMBH &CO KG5
CHARITE UNIVERSITAETSMEDIZIN BERLIN5
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM5
GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT5
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE5
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE5
MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN5
UCB BIOPHARMA5
UNIVERSITY COLLEGE LONDON5
FORUM DES PATIENTS EUROPEENS4
KING'S COLLEGE LONDON4
LEIDS UNIVERSITAIR MEDISCH CENTRUM4
STICHTING LYGATURE4
TAKEDA DEVELOPMENT CENTRE EUROPE4
TEAM IT RESEARCH SL4
TEVA PHARMACEUTICAL INDUSTRIES LIMITED4
THE PROVOST FELLOWS AND SCHOLARS OF THE COLLEGE OF THE HOLY AND UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLIN HEREINAFTER TRINITY COLLEGE DUBLIN4
THE UNIVERSITY OF MANCHESTER4
UNIVERSITA VITASALUTE SAN RAFFAELE4
UNIVERSITAET ZUERICH4
UNIVERSITY OF COPENHAGEN4
UPPSALA UNIVERSITET4
ACADEMIC MEDICAL CENTRE AMSTERDAM3
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE3
ELI LILLY AND COMPANY3
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V3
LEIDEN UNIVERSITY3
MEDIZINISCHE UNIVERSITAET WIEN3
MERCK SHARP & DOHME CORP3
QUEEN MARY AND WESTFIELD COLLEGE UNIVERSITY OF LONDON3
SYDDANSK UNIVERSITET3
THE EUROPEAN INSTITUTE FOR INNOVATION THROUGH HEALTH DATA3
UNIVERSITAETSKLINIKUM FREIBURG3
UNIVERSITAT WIEN3
UNIVERSITEIT UTRECHT3
UNIVERSITY COLLEGE DUBLIN3
UNIVERSITY OF CAMBRIDGE3
UNIVERSITY OF GLASGOW3
UNIVERSITY OF NEWCASTLE UPON TYNE3
UNIVERSITY OF TAMPERE3
ACADEMISCH ZIEKENHUIS GRONINGEN2
ACCADEMIA EUROPEA PER LA RICERCA APPLICATA ED IL PERFEZIONAMENTO PROFESSIONALE BOLZANO2
ALLERGAN LIMITED2
CHRISTIAN ALBRECHTS UNIVERSITAET ZU KIEL2
CLINIQUES UNIVERSITAIRES SAINTLUC2
CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER2
DREEM2
DRESDEN UNIVERSITY OF TECHNOLOGY2
EATRIS ERIC2
ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE2
ECRIN EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK2
EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH2
ELI LILLY AND COMPANY LIMITED2
EMPIRICA GESELLSCHAFT FUR KOMMUNIKATIONS UND TECHNOLOGIEFORSCHUNG MBH2
ETHNIKO KENTRO EREVNAS KAI TECHNOLOGIKIS ANAPTYXIS2
EURICE EUROPEAN RESEARCH AND PROJECT OFFICE2
EUROPEAN LUNG FOUNDATION2
EUROPEAN RESPIRATORY SOCIETY2
FRIEDRICHALEXANDERUNIVERSITAET ERLANGEN NUERNBERG2
FUNDACION PARA EL FOMENTO DE LA INVESTIGACION SANITARIA Y BIOMEDICA DE LA COMUNITAT VALENCIANA2
GRUNENTHAL2
GSF FORSCHUNGSZENTRUM FUER UMWELT UND GESUNDHEIT2
HELSE STAVANGER HF2
INSTITUT DE RECHERCHES INTERNATIONALES SERVIER IRIS2
INSTITUT DE RECHERCHES SERVIER2
INSTITUTE OF ORGANIC CHEMISTRY POLISH ACADEMY OF SCIENCES2
INSTITUTO DE MEDICINA MOLECULAR JOAO LOBO ANTUNES2
IXSCIENT LIMITED2
LUDWIG MAXIMILIANS UNIVERSITAET MUENCHEN2
LUND UNIVERSITY2
MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH2
MAX PLANCK GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN EV2
MCROBERTS BV2
MDSOL EUROPE2
MEDTRONIC INTERNATIONAL TRADING SARL2
NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS2
NORGES TEKNISKNATURVITENSKAPELIGE UNIVERSITET NTNU2
NOVO NORDISK2
OWKIN FRANCE2
PARKINSON'S DISEASE SOCIETY OF THEUNITED KINGDOM LBG2
REGION STOCKHOLM2
RIJKSINSTITUUT VOOR VOLKSGEZONDHEID EN MILIEU2
RISE RESEARCH INSTITUTES OF SWEDEN AB2
SERVICIO MADRILENO DE SALUD2
STICHTING MLC FOUNDATION2
STICHTING VUMC2
THE HYVE BV2
THE UNIVERSITY OF EDINBURGH2

Constancy:

Total number of partners: 747
Partner loyalty:
Frequent Partner: (> 2 projects): 260
Rare Partner: 487
Frequent / Rare Partner Ratio: 0.53

Project overview:

Start dateProjectacronymrolefundingpartners
2022-09-01Boosting the reduction of the environmental impact of pharmaceutical products throughout their entire life cycle. ETERNALparticipant5.922.39616
2022-09-01Gene Therapy of Rare Diseases GetRadiparticipant2.785.81014
2022-09-01Assessing efficacy and safety of genome EDITing approaches for Sickle Cell Disease EDITSCDparticipant6.001.2508
2022-05-01Next generation advanced RNA inhibition therapy to treat cardiometabolic disease LiverTargetparticipant6.000.0009
2022-01-01FrAmework for ClInicaL trIal participants daTA reutilization for a fully Transparent and Ethical ecosystem FACILITATEparticipant3.260.00029
2021-11-01Preparing for RSV Immunisation and Surveillance in Europe PROMISEparticipant3.744.37522
2021-10-01Optimal treatment for patients with solid tumours in Europe through Artificial intelligence OPTIMAparticipant10.459.99739
2021-07-01Building a reproducible single-cell experimental workflow to capture tumour drug persistence PERSIST-SEQparticipant7.057.98016
2021-07-01Real World Handling of Protein Drugs - Exploration, Evaluation and Education RealHOPEparticipant3.139.98425
2021-05-01ENable LIGHT- and synthetic biology-driven volumetric bioprinting of functional human tissues ENLIGHTparticipant3.594.9258
2021-01-01Boosting advanced doctoral training in innovative colon targeting drugs COLOTANparticipant3.533.10810
2021-01-01EU Training Network in understanding the molecular regulation and the role of endo-lysosomal processes in cardio-metabolic diseases EndoConnectparticipant4.050.84912
2021-01-01Oligonucleotides for Medical Applications OLIGOMEDparticipant4.153.34413
2021-01-01Advanced machine learning for Innovative Drug Discovery AIDDparticipant3.926.61516
2021-01-01A fully integrated, animal-free, end-to-end modelling approach to oral drug product development InPharmaparticipant3.464.96411
2020-11-01Gravitate–Health: Empowering and Equipping Europeans with health information for Active Personal Health Management and Adherence to Treatment Gravitate-Healthparticipant9.280.00042
2020-10-01H2O Health Outcomes Observatory H2Oparticipant10.476.68725
2020-09-01NExt ApplicationS of Quantum Computing NEASQCparticipant4.671.33315
2020-09-01Prioritisation and Risk Evaluation of Medicines in the EnviRonment PREMIERparticipant4.550.00025
2020-07-01C-H Activation for Industrial Renewal CHAIRparticipant3.938.27014
2020-02-01Cooperation towards a sustainable chemical industry CO2PERATEparticipant4.140.66110
2020-01-01PharmaLedger PharmaLedgerparticipant8.290.69430
2020-01-01Multidisciplinary Training in Chronic Kidney Disease: from genetic modifiers to drug discovery TrainCKDisparticipant4.017.84810
2019-11-01Identifying Digital Endpoints to Assess FAtigue, Sleep and acTivities in daily living in Neurodegenerative disorders and Immune-mediated inflammatory diseases IDEA-FASTparticipant20.997.52347
2019-11-01EU Patient- cEntric clinicAl tRial pLatform EU-PEARLparticipant12.004.95337
2019-10-01PancREatic Cancer OrganoiDs rEsearch Network PRECODEparticipant3.992.89215
2019-09-01Trials@Home: Center of Excellence – Remote Decentralised Clinical Trials Trials@Homeparticipant19.036.99833
2019-09-01EXpanding Platforms for Efficacious mRNA Therapeutics EXPERTparticipant14.931.33811
2019-09-01Identification of the Molecular Mechanisms of non-response to Treatments, Relapses and Remission in Autoimmune, Inflammatory, and Allergic Conditions 3TRparticipant40.273.19270
2019-06-01MachinE Learning Ledger Orchestration for Drug DiscoverY MELLODDYparticipant8.000.00017
2019-05-01Saracatinib Trial tO Prevent FOP STOPFOPparticipant999.7106
2019-05-01Parkinson Disease with Mild cognition Impairment treated with Nicotinic agonist Drug PD-MINDparticipant999.69810
2019-05-01INnate-ImmunomeTabolIsm as Antiviral TargEt INITIATEparticipant4.054.10614
2019-04-01Connecting digital mobility assessment to clinical outcomes for regulatory and clinical endorsement MOBILISE-Dparticipant25.395.89735
2019-03-01Neurotoxicity De-Risking in Preclinical Drug Discovery NeuroDeRiskparticipant5.331.00018
2019-03-01A multidisciplinary approach towards sustainable improvement in rare diseases care uniting Europe's top class vascular research to find new treatment strategies for vascular anomalies V.A. Cureparticipant3.792.13617
2019-01-01FAIRplus FAIRplusparticipant3.996.15022
2019-01-01Stirling heat pump for high temperature industrial use Highliftparticipant2.439.5123
2019-01-01A European Training Network to Combat Bone Pain BonePainIIparticipant4.291.66512

Alias institution names:

  • ASTRAZENECA